Skip to content

Cerebras Systems

US · CBRS #529 by market cap Listed 2026
175.05 -2.05 -1.16%
Live - 5344 symbols - heartbeat 52s ago · 2026-10-08 06:50
Pre-market 171.70 -1.91%
After-hours 175.53 +0.27%
Overnight 172.60 -1.40%
Market cap
41.59B
P/B
4.54
EPS
0.41
Reader sentiment Are you bullish or bearish on CBRS?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 4.61 Expensive vs history 68th percentile
5-year average -100.17 · #34 of 69 in Semiconductors
P/E ratio -83.21 Cheap vs history 15th percentile
5-year average 280.13 · forward -86.74
P/S ratio 62.00 Cheap vs history 10th percentile
5-year average 76.57 · forward 28.93 · #66 of 69 in Semiconductors

Vs. peers Semiconductors

Company Market cap P/E (TTM) P/B Div yield
Cerebras Systems (CBRS) 41.59B -81.99 4.54 0.00%
NVIDIA (NVDA) 5.72T 30.02 24.99 0.12%
Taiwan Semiconductor (TSM) 2.45T 35.24 12.15 0.73%
Broadcom (AVGO) 1.80T 48.02 18.03 0.67%
SK hynix (SKHY) 1.30T 23.16 10.59 0.00%
Micron Technology (MU) 1.23T 14.64 8.88 0.05%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value195.39 Economic moatNarrow UncertaintyVery High

Trading 11.6% below Morningstar's fair value estimate.

Fair value

Cerebras Systems Inc earns a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 9% discount to our quantitative fair value estimate of $195.39 per share; however, caution is warranted due to this estimate's very high uncertainty rating.

The firm's solid growth strengthens our fair value estimate. Consistent revenue and earnings growth indicates a company's potential for increased market share and profitability. For example, the firm's revenue 3-year growth ranks in the top 1% globally. Robust trailing three-year revenue growth portends a favorable future trajectory, which contributes to our view that shares are cheap.

On a different note, the company's lack of profitability is potentially concerning. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of -1.5%, a core component of profitability, falls in the bottom 30% compared with peers globally. The earnings generated by the company relative to its share price is concerning, which, despite our favorable price/fair value ratio, is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has been a laggard relative to the broader universe over the past year. This underperformance makes the stock appear cheap, which portends a buying opportunity in light of other contributors to our model.

Economic moat

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-10-08 06:50:15 · For reference only, not investment advice and not tailored to your situation.